Investing Profile
Gregory Harriman
InvestorVCAngel
Partner, Chief Investment Officer at BioAdvance
bioadvance.com/team/gregory-h...Pennsylvania
Your Intro Paths to Gregory Harriman
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Networks Gregory is a member of
University of California, Berkeley Network
251 CONNECTIONS
Johnson & Johnson Network
17 CONNECTIONS
Find Gregory Harriman on
cbCurrent Investing Position
BioAdvance Partner
Investment Range
$1.5M - $5.0M
Sweet Spot
$3.3M
Investments On Record
3
Gregory Harriman is on these Sector & Stage Rankings
Gregory Harriman's Investments On Record (2)
| Company | StageDateRound Size | Total Raised |
|---|---|---|
Senzo | SeedDec 2022$2M SeedJul 2022$2M | $4M |
Opsidio | Series UnknownSep 2017$500K | $500K |
Gregory Harriman's Experience
Director Senzo Health2022 - Present
Partner, Chief Investment Officer BioAdvance2021 - Present
Director Opsidio, LLC2017 - Present
Director Treventis2012 - Present
President Main Line Ventures2006 - Present
Director RIBONOVA INC.2016 - 2021
Venture Partner BioAdvance2012 - 2021
Director Genome Profiling, LLC2017 - 2018
Director Enzium, Inc.2015 - 2017
Director Immunome2012 - 2017
Member Robin Hood Ventures2010 - 2017
Director QR Pharma2012 - 2014
Research Professor, School of Biomedical Engineering, Science and Health Systems Drexel University2010 - 2014
Director Novira Therapeutics2011 - 2012
Vice President Johnson & Johnson2001 - 2009
Executive Director Centocor1998 - 2001
Medical Director IVAX1996 - 1998
Assistant Professor of Medicine Baylor College of Medicine1991 - 1996
Gregory Harriman's Education
UC San Diego School of Medicine M.D. Medicine
University of California, Berkeley
Founders who looked at Gregory Harriman's profile also looked at these Investors
Founders who looked at Gregory Harriman's profile also looked at these Scouts & Angels